Fox, Robert J. https://orcid.org/0000-0002-4263-3717
Article History
First Online: 25 May 2021
Competing interests
: R.J.F. has received personal consulting fees from AB Science, Actelion, Biogen, Celgene, EMD Serono, Genentech, Immunic, Novartis, Sanofi and TG Therapeutics; served on advisory committees for Actelion, Biogen, Immunic, Novartis and Sanofi; and received clinical trial contract and research grant funding from Biogen, Novartis and Sanofi.